Biotyping, virulotyping and biofilm formation ability of ESBL-Klebsiella pneumoniae isolates from nosocomial infections
- PMID: 35384170
- DOI: 10.1111/jam.15563
Biotyping, virulotyping and biofilm formation ability of ESBL-Klebsiella pneumoniae isolates from nosocomial infections
Abstract
The aim of this study was to investigate the frequency, molecular characterization, virulence genes, resistance genes and antimicrobial profile of nosocomial extended spectrum beta lactamase producing Klebsiella species. A total of 22 (12.2%) K. pneumoniae strains were isolated from 180 clinical samples collected from hospitalized patients in Egypt. K. pneumoniae biotypes were B1 (72.8%), B3 (13.6%) and B4 (13.6%). The isolates were classified for the capsular serotypes, 86.4% (20/22) were of K1 serotype, while only two isolates (13.64%) were of K2 serotype. Hypermucoviscous K. pneumoniae isolates accounted for 68.2%. Biofilm formation ability of K. pneumoniae was determined by microtitre plate method. The majority of the isolates (40.9%) were moderate biofilm producers, while 27.3% were strong biofilm producers. All K. pneumoniae strains were positive for fimH and traT genes, while magA was identified in only 63.6% of the isolates. The antibiotic susceptibility profile of the isolates (n = 22) was determined by the disc diffusion technique using 23 different antibiotics. Streptomycin and imipenem are the most effective antibiotics against 22 tested K. pneumoniae isolates with sensitivity rates of 63.64% and 54.54% respectively. All tested K. pneumoniae isolates showed high resistance to amoxicillin∕clavulanate (100%), cefuroxime (100%) and ceftazidime (95.45%). Extended spectrum beta lactamases (ESBL) production and the presence of ESBL-related genes were tested in the isolates. All the isolates tested positive for blaVIM, NDM1 and blaTEM, while only 81.8 %tested positive for the blaSHV gene. Increasing antimicrobial resistance in K. pneumoniae causing nosocomial infections limits the use of antimicrobial agents for treatment. Furthermore, the spread of biofilm, multiple drug resistant and ESBL-producing K. pneumoniae isolates is a public threat for hospitalized patients.
Keywords: Klebsiella pneumoniae; biofilm; extended Spectrum Beta lactamases; multidrug resistance; nosocomial infection.
© 2022 Society for Applied Microbiology.
Similar articles
-
Multidrug-resistant Klebsiella pneumoniae harboring extended spectrum β-lactamase encoding genes isolated from human septicemias.PLoS One. 2021 May 4;16(5):e0250525. doi: 10.1371/journal.pone.0250525. eCollection 2021. PLoS One. 2021. PMID: 33945553 Free PMC article.
-
An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.Infect Disord Drug Targets. 2019;19(1):46-54. doi: 10.2174/1871526518666180507121831. Infect Disord Drug Targets. 2019. PMID: 29732983
-
Biofilm Formation and Associated Gene Expression in Multidrug-Resistant Klebsiella pneumoniae Isolated from Clinical Specimens.Curr Microbiol. 2022 Jan 27;79(3):73. doi: 10.1007/s00284-022-02766-z. Curr Microbiol. 2022. PMID: 35084583
-
Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies.Front Cell Infect Microbiol. 2024 Feb 23;14:1324895. doi: 10.3389/fcimb.2024.1324895. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38465230 Free PMC article. Review.
-
Klebsiella pneumoniae: an update on antibiotic resistance mechanisms.Future Microbiol. 2023 Jan;18:65-81. doi: 10.2217/fmb-2022-0097. Epub 2023 Jan 12. Future Microbiol. 2023. PMID: 36632990 Review.
Cited by
-
Global quantitative proteome analysis of a multi-resistant Klebsiella pneumoniae strain.Front Microbiol. 2025 May 19;16:1528869. doi: 10.3389/fmicb.2025.1528869. eCollection 2025. Front Microbiol. 2025. PMID: 40458706 Free PMC article.
-
Phage vB_Kpn_HF0522: Isolation, Characterization, and Therapeutic Potential in Combatting K1 Klebsiella pneumoniae Infections.Infect Drug Resist. 2025 Feb 10;18:803-818. doi: 10.2147/IDR.S501921. eCollection 2025. Infect Drug Resist. 2025. PMID: 39958984 Free PMC article.
References
REFERENCES
-
- AbdEl-Mongy, M., Othman, A.S. & Elkhateeb, H.A. (2018) In vitro detection of antibacterial activity of Glycyrrhizic acid nanoparticle against ESBL producing Klebsiella pneumoniae strains. Egyptian Journal of Microbiology, 53, 193-205.
-
- Ahmed, O.I., El-Hady, S.A., Ahmed, T.M. & Ahmed, I.Z. (2013) Detection of Bla SHV and Bla CTX-M genes in ESBL producing Klebsiella pneumoniae isolated from Egyptian patients with suspected nosocomial infections. Egyptian Journal of Medical Human Genetics, 14, 277-283.
-
- Aitta, A., El Said, M., Gamal, D., El-Kholy, A., Omer, M., Kamel, M. et al. (2013) Biotyping and molecular characterization of Klebsiella pneumoniae producing extended-spectrum beta-lactamase in Cairo, Egypt: a multicenter study. Researcher, 5, 1-11.
-
- Alcántar-Curiel, M.D., Blackburn, D., Saldaña, Z., Gayosso-Vázquez, C., Iovine, N., De la Cruz, M.A. et al. (2013) Multi-functional analysis of Klebsiella pneumoniae fimbrial types in adherence and biofilm formation. Virulence, 4, 129-138.
-
- Alsanie, W.F. (2020) Molecular diversity and profile analysis of virulence-associated genes in some Klebsiella pneumoniae isolates. Practical Laboratory Medicine, 19, e00152.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources